查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1426127

给药系统市场：按产品、给药途径、应用、最终用户和地区划分的机会和预测（2017-2031）

Drug Delivery Systems Market Assessment, By Product, By Route of Administration, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 225 Pages | 商品交期: 3-5个工作天内

价格

全球给药系统市场规模预计将从2023年的1,516亿美元成长到2031年的3,051.9亿美元，预测期间内复合年增长率为9.14%。

塑造全球药物输送系统市场的动力包括慢性病的增加、自我给药设备需求的激增、技术进步、老年人口的成长、生物製剂和高分子药物的成长，其中包括增加投资、合作伙伴关係、新兴市场的快速成长、支持性监管框架以及个人化医疗的出现。

受多种因素影响，全球给药系统市场正经历重大转型。 癌症、糖尿病和心血管疾病等慢性病的盛行率不断上升是一个关键驱动因素，凸显了对更有效、更有针对性的药物传递方法的需求。 此外，对治疗便利性和自我控制的渴望导致患者对自我管理工具的偏好显着增加。 此外，技术的不断进步在增强药物输送系统方面发挥着重要作用。 此外，不断增长的老年人口凸显了对专为老年人设计的客製化输送系统的需求。

此外，世界各国政府正积极实施各种计划，以促进全球给药系统市场的扩大。 这些努力包括多种方法，例如激励研发、简化监管流程以加快审批速度，以及提供财务支援和补助金以鼓励创新。 此外，一些政府正在促进学术机构、产业和研究中心之间的伙伴关係，以促进技术转移并鼓励对先进药物传输技术的投资。

本报告调查了全球药物输送系统市场，提供了市场定义和概述、市场规模趋势和预测、各个细分市场和地区的详细分析、行业结构以及影响市场成长的因素。我们编制分析、案例研究、竞争景观、主要公司简介等等。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第四章全球给药系统市场展望

  • 市场规模/预测
  • 按产品
    • 预灌封注射器
    • 自动注射器
    • 输液泵
    • 定量吸入器 (MDI)
    • 雾化器
    • 滴鼻剂
    • 滴管
    • 子宫内避孕器 (IUD)
  • 依给药途径
    • 药物输送至肺部
    • 经由黏膜给药
    • 鼻腔给药
    • 口服给药
    • 局部给药
    • 植入式药物输送
    • 注射给药
    • 眼科药物输送
  • 依用途
    • 自体免疫疾病
    • 心血管疾病
    • 癌症
    • 传染病
    • 呼吸系统疾病
    • 中枢神经系统疾病
    • 糖尿病
    • 其他
  • 按最终用户
    • 医院
    • 门诊手术中心
    • 居家护理
    • 诊断中心
    • 其他
  • 按地区
    • 北美
    • 欧洲
    • 南美洲
    • 亚太地区
    • 中东/非洲
  • 各公司的市占率

第 5 章全球给药系统市场前景：按地区划分

  • 北美
  • 欧洲
  • 南美洲
  • 亚太地区
  • 中东/非洲

第 6 章市场映射

  • 按产品
  • 依给药途径
  • 依用途
  • 按最终用户
  • 按地区

第七章宏观环境与产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

  • 生长促进因素
  • 抑製成长的因素（问题/限制）

第 9 章监理架构与创新

  • 临床试验
  • 专利情况
  • 监理机关的核准
  • 创新/最新技术

第十章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家参与公司）
  • 专利分析（如果适用）

第11章价格分析

第 12 章案例研究

第十三章主要公司展望

  • Sharps Technology Inc.
  • Becton, Dickinson and Company
  • Cardinal Health
  • Novo Nordisk A/S
  • Terumo Corporation
  • Insulet Corporation
  • Enable Injections, Inc.
  • Bespak Europe Ltd.
  • West Pharmaceutical Services, Inc.
  • Novartis International AG
  • Merck & Co., Inc.
  • Sanofi S.A.

第 14 章策略建议

第十五章关于我们公司/免责声明

Product Code: MX10990

Global drug delivery systems market is projected to witness a CAGR of 9.14% during the forecast period 2024-2031, growing from USD 151.6 billion in 2023 to USD 305.19 billion in 2031. The dynamics shaping the global drug delivery systems market encompass a spectrum of elements, such as the escalation of chronic diseases, the surge in demand for self-administration devices, advancements in technology, the growth of the geriatric population, the prominence of biologics and large molecule drugs, increased investment, collaborative partnerships, the burgeoning market in emerging economies, supportive regulatory frameworks, and the advent of personalized medicine.

The global drug delivery systems market is in a phase of significant transformation, driven by a diverse range of influential factors. The escalating incidence of chronic diseases, such as cancer, diabetes, and cardiovascular conditions, serve as a pivotal force, stimulating the need for more efficient and targeted drug delivery methods. Concurrently, there's a notable surge in patient preference for self-administration tools, aiming for convenience and self-management in their therapies. Furthermore, the continual advancement of technology assumes a crucial role in enhancing drug delivery systems. Additionally, the increasing elderly population, with its unique healthcare requirements, underscores the demand for tailor-made delivery systems designed specifically for older individuals in the global drug delivery systems market.

The global drug delivery systems market configuration is further influenced by the prominence of biologics and large molecule drugs, necessitating sophisticated delivery platforms to ensure efficient administration. Collaborative alliances between pharmaceutical firms and research institutions drive innovation, accelerating the creation and commercialization of pioneering delivery systems. Concurrently, the burgeoning healthcare markets in developing economies present unexplored avenues for expansion, buoyed by supportive regulatory frameworks that facilitate research and development ventures. The emergence of personalized medicine, focused on customized therapies tailored to individual patient needs, signifies a substantial shift, fueling the quest for personalized drug delivery solutions on a global scale and boosting the global drug delivery systems market.

Surge in Demand for Self-Administration Devices

The rising demand for self-administration devices is a key catalyst driving the global drug delivery systems market expansion. Patients increasingly desire independence and ease in handling their treatments, resulting in a noticeable uptick in the uptake of such devices. These self-administration solutions, including injectable pens, wearable technologies, and other user-friendly tools, grant patients' greater autonomy in managing their therapies, simplifying the treatment process. This upsurge mirrors a change in patient preferences and underscores a fundamental shift in healthcare delivery, highlighting the significance of personalized and convenient treatment choices. As a result, the market for drug delivery systems is experiencing substantial growth, fueled by the escalating preference for self-administration devices among healthcare consumers worldwide.

Increased Investments

Numerous corporations are reinforcing their financial commitments in the global drug delivery systems sector, demonstrated through the creation of fresh production facilities. This strategic endeavor entails the construction of cutting-edge sites geared towards manufacturing sophisticated drug delivery systems. By expanding their manufacturing prowess, firms endeavor to satisfy increasing market needs, pioneer inventive delivery approaches, and streamline production efficiency. These investments reflect a dedication to augment research, development, and production capabilities, enabling the companies to seize the burgeoning prospects within the ever-changing pharmaceutical arena.

For instance, in March 2023, Genixus, a firm dedicated to producing and creating drug delivery systems, declared the completion of a new manufacturing facility in Concord, N.C. The site is equipped with automated manufacturing and state-of-the-art technology specifically designed to bolster the KinetiX syringe platform and broaden its product range. This increase in manufacturing capability is a direct response to the market's call for ready-to-administer (RTA) syringes.

Government Initiatives

Governments globally are proactively executing various programs to nurture the expansion of the worldwide drug delivery systems market. These initiatives involve diverse approaches like incentivizing research and development, simplifying regulatory processes to hasten approvals, and offering financial aid or grants to spur innovation. Furthermore, certain governments are cultivating partnerships between educational institutions, industries, and research centers, easing the transfer of technology, and encouraging investments in sophisticated drug delivery technologies. These extensive actions reflect a unified endeavor to propel progress in drug delivery systems, aiming for enhanced treatments, improved patient results, and meeting evolving healthcare demands globally.

For example, in February 2021, the Union Cabinet of India approved the Production Linked Incentive (PLI) initiative tailored for the pharmaceutical sector. The scheme aims to elevate India's manufacturing capacities by augmenting investments and production within the sector, fostering the expansion of product diversity towards high-value pharmaceutical goods. Additionally, the scheme seeks to cultivate globally competitive entities in India, empowering them to expand in scope and magnitude by integrating advanced technology, thus enabling their integration into global value chains.

Growing demand for Autoinjectors

There's a notable increase in the global drug delivery systems market's interest in autoinjectors. These tools facilitate patient-friendly, self-administered medication, especially advantageous for individuals needing regular injections. The escalating incidence of chronic illnesses and the preference for home-based healthcare solutions play a role in driving this escalated need. Autoinjectors ensure accuracy in dosing, ease of use, and a decrease in medical mistakes, promoting patient adherence to treatments. Additionally, technological advancements, improvements in design, and the widening application of injectable medications in various therapeutic areas contribute to the growing acceptance of autoinjectors. Consequently, they emerge as a pivotal driver in the expansion of the drug delivery systems market.

For instance, in September 2023, Ypsomed, a Swiss medical technology firm, disclosed a prolonged supply agreement with Novo Nordisk for autoinjectors. This partnership highlights the advantageous impact of the Danish pharmaceutical company's weight-loss drug business on firms specializing in pharmaceutical services. Ypsomed plans to increase its production capacities in the upcoming years, with Novo Nordisk playing a substantial role by investing in the added production infrastructure.

Drug Delivery Systems for Diabetes

The escalating demand for drug delivery systems tailored for diabetes treatment significantly drives growth within the global drug delivery systems market. Diabetes, a prevalent chronic condition, requires consistent and precise medication administration. This heightened demand stems from the need for effective delivery mechanisms ensuring optimized drug dosing, improved patient compliance, and reduced treatment-associated complications. With advancements in diabetes management and the expansion of therapeutic options, the market experiences an upsurge in innovative drug delivery systems catering specifically to diabetic patients, thereby contributing substantially to the market's expansion and evolution.

For example, Terumo India, the Indian division of Terumo Corporation, a prominent global player in medical technology, unveiled an insulin syringe on November 14, 2023. This sterile delivery device caters to patients needing frequent insulin injections, elevating standards for patient comfort and adherence to therapy.

Future Market Scenario (2024-2031F)

The future prospects of the global drug delivery systems market display a high level of promise. Several factors contribute to this positive outlook, notably ongoing technological advancements that consistently refine drug delivery techniques. These innovations result in more accurate, targeted, and efficient medication administration, elevating treatment effectiveness, while reducing potential side effects. Moreover, the escalating prevalence of chronic diseases like cancer, diabetes, and cardiovascular ailments worldwide drives the demand for advanced drug delivery systems. This need is amplified by an increasingly aging population requiring specialized treatment modalities. Additionally, the industry's response to global health crises, such as the COVID-19 pandemic, has expedited research and development, yielding rapid progress in vaccine delivery methods and therapeutics. The continual expansion of healthcare infrastructure in emerging economies and the emphasis on personalized medicine further propels the ongoing evolution and potential expansion of the global drug delivery systems market.

Key Players Landscape and Outlook

The global drug delivery systems market is currently witnessing a series of acquisitions. These strategic moves involve companies acquiring or merging with other entities to expand their product portfolios, enhance market presence, or access novel technologies. Acquisitions offer opportunities for companies to consolidate their positions, capitalize on synergies, and gain competitive advantages. They facilitate access to new markets, diversification of offerings, and acceleration of innovation by integrating complementary expertise. These transactions signify a dynamic phase within the drug delivery systems industry, aimed at reinforcing market foothold and fostering growth through strategic partnerships and expansions.

For instance, in July 2023, Novartis, a Swiss multinational pharmaceutical corporation, completed the acquisition of DTx Pharma, a startup specializing in RNA medicine delivery, for $500 million. DTx Pharma's Fatty Acid Ligand Conjugated Oligonucleotide (FALCON) platform enables the delivery of siRNA therapeutics outside the liver.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Drug Delivery Systems Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. Value
    • 4.1.2. Volume
  • 4.2. By Product
    • 4.2.1. Prefilled Syringes
    • 4.2.2. Autoinjectors
    • 4.2.3. Infusion Pumps
    • 4.2.4. Metered Dose Inhalers (MDIs)
    • 4.2.5. Nebulizers
    • 4.2.6. Nasal Sprays
    • 4.2.7. Eyedroppers
    • 4.2.8. Intrauterine Devices (IUDs)
  • 4.3. By Route of Administration
    • 4.3.1. Pulmonary Drug Delivery
    • 4.3.2. Transmucosal Drug Delivery
    • 4.3.3. Nasal Drug Delivery
    • 4.3.4. Oral Drug Delivery
    • 4.3.5. Topical Drug Delivery
    • 4.3.6. Implantable Drug Delivery
    • 4.3.7. Injectable Drug Delivery
    • 4.3.8. Ocular Drug Delivery
  • 4.4. By Application
    • 4.4.1. Autoimmune Diseases
    • 4.4.2. Cardiovascular Diseases
    • 4.4.3. Cancer
    • 4.4.4. Infectious Diseases
    • 4.4.5. Respiratory Diseases
    • 4.4.6. Central Nervous System Diseases
    • 4.4.7. Diabetes
    • 4.4.8. Others
  • 4.5. By End-user
    • 4.5.1. Hospitals
    • 4.5.2. Ambulatory Surgical Centers
    • 4.5.3. Home Care Settings
    • 4.5.4. Diagnostic Centers
    • 4.5.5. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. South America
    • 4.6.4. Asia-Pacific
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Drug Delivery Systems Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. Value
      • 5.1.1.2. Volume
    • 5.1.2. By Product
      • 5.1.2.1. Prefilled Syringes
      • 5.1.2.2. Autoinjectors
      • 5.1.2.3. Infusion Pumps
      • 5.1.2.4. Metered Dose Inhalers (MDIs)
      • 5.1.2.5. Nebulizers
      • 5.1.2.6. Nasal Sprays
      • 5.1.2.7. Eyedroppers
      • 5.1.2.8. Intrauterine Devices (IUDs)
    • 5.1.3. By Route of Administration
      • 5.1.3.1. Pulmonary Drug Delivery
      • 5.1.3.2. Transmucosal Drug Delivery
      • 5.1.3.3. Nasal Drug Delivery
      • 5.1.3.4. Oral Drug Delivery
      • 5.1.3.5. Topical Drug Delivery
      • 5.1.3.6. Implantable Drug Delivery
      • 5.1.3.7. Injectable Drug Delivery
      • 5.1.3.8. Ocular Drug Delivery
    • 5.1.4. By Application
      • 5.1.4.1. Autoimmune Diseases
      • 5.1.4.2. Cardiovascular Diseases
      • 5.1.4.3. Cancer
      • 5.1.4.4. Infectious Diseases
      • 5.1.4.5. Respiratory Diseases
      • 5.1.4.6. Central Nervous System Diseases
      • 5.1.4.7. Diabetes
      • 5.1.4.8. Others
    • 5.1.5. By End-user
      • 5.1.5.1. Hospitals
      • 5.1.5.2. Ambulatory Surgical Centers
      • 5.1.5.3. Home Care Settings
      • 5.1.5.4. Diagnostic Centers
      • 5.1.5.5. Others
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
      • 5.1.6.1.1. Value
      • 5.1.6.1.2. Volume
      • 5.1.6.2. By Product
      • 5.1.6.2.1. Prefilled Syringes
      • 5.1.6.2.2. Autoinjectors
      • 5.1.6.2.3. Infusion Pumps
      • 5.1.6.2.4. Metered Dose Inhalers (MDIs)
      • 5.1.6.2.5. Nebulizers
      • 5.1.6.2.6. Nasal Sprays
      • 5.1.6.2.7. Eyedroppers
      • 5.1.6.2.8. Intrauterine Devices (IUDs)
      • 5.1.6.3. By Route of Administration
      • 5.1.6.3.1. Pulmonary Drug Delivery
      • 5.1.6.3.2. Transmucosal Drug Delivery
      • 5.1.6.3.3. Nasal Drug Delivery
      • 5.1.6.3.4. Oral Drug Delivery
      • 5.1.6.3.5. Topical Drug Delivery
      • 5.1.6.3.6. Implantable Drug Delivery
      • 5.1.6.3.7. Injectable Drug Delivery
      • 5.1.6.3.8. Ocular Drug Delivery
      • 5.1.6.4. By Application
      • 5.1.6.4.1. Autoimmune Diseases
      • 5.1.6.4.2. Cardiovascular Diseases
      • 5.1.6.4.3. Cancer
      • 5.1.6.4.4. Infectious Diseases
      • 5.1.6.4.5. Respiratory Diseases
      • 5.1.6.4.6. Central Nervous System Diseases
      • 5.1.6.4.7. Diabetes
      • 5.1.6.4.8. Others
      • 5.1.6.5. By End-user
      • 5.1.6.5.1. Hospitals
      • 5.1.6.5.2. Ambulatory Surgical Centers
      • 5.1.6.5.3. Home Care Settings
      • 5.1.6.5.4. Diagnostic Centers
      • 5.1.6.5.5. Others
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Route of Administration
  • 6.3. By Application
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Sharps Technology Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Becton, Dickinson and Company
  • 13.3. Cardinal Health
  • 13.4. Novo Nordisk A/S
  • 13.5. Terumo Corporation
  • 13.6. Insulet Corporation
  • 13.7. Enable Injections, Inc.
  • 13.8. Bespak Europe Ltd.
  • 13.9. West Pharmaceutical Services, Inc.
  • 13.10. Novartis International AG
  • 13.11. Merck & Co., Inc.
  • 13.12. Sanofi S.A.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 5. Global Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Drug Delivery Systems Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 11. North America Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 12. North America Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Drug Delivery Systems Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 18. United States Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 19. United States Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 24. Canada Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 25. Canada Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 30. Mexico Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 31. Mexico Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 36. Europe Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 37. Europe Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Drug Delivery Systems Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 43. Germany Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 44. Germany Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 49. France Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 50. France Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 51. France Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 55. Italy Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 56. Italy Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 61. United Kingdom Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 62. United Kingdom Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 67. Russia Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 68. Russia Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 73. Netherlands Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 74. Netherlands Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 79. Spain Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 80. Spain Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 85. Turkey Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 86. Turkey Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 91. Poland Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 92. Poland Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 97. South America Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 98. South America Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Drug Delivery Systems Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 104. Brazil Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 105. Brazil Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 110. Argentina Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 111. Argentina Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 116. Asia-Pacific Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 117. Asia-Pacific Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Drug Delivery Systems Market Share (%), By Country, 2017-2031F
  • Figure 120. India Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 123. India Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 124. India Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 125. India Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 129. China Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 130. China Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 131. China Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 135. Japan Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 136. Japan Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 141. Australia Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 142. Australia Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 147. Vietnam Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 148. Vietnam Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 153. South Korea Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 154. South Korea Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 159. Indonesia Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 160. Indonesia Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 165. Philippines Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 166. Philippines Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 171. Middle East & Africa Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 172. Middle East & Africa Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Drug Delivery Systems Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 178. Saudi Arabia Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 179. Saudi Arabia Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 184. UAE Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 185. UAE Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Drug Delivery Systems Market Share (%), By Product, 2017-2031F
  • Figure 190. South Africa Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
  • Figure 191. South Africa Drug Delivery Systems Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Route of Administration Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023